Why MammaPrint

 

  • When biology speaks, we listen: Agendia’s technology allows continuous transformation to grow Agendia’s product profile into new areas and information by listening, adapting and learning about the always changing biology of cancer.

 

  • The SymphonyTM Personalized Breast Cancer Profile: Agendia offers a variety of breast cancer assays to help personalize the patient's treatment by looking at what their likelihood of recurrence truely is.

 

  • Patient Safety: 98.4% accuracy of patient’s recurrence on their untreated specimen

MammaPrint, along with the other tests included in the Symphony profile by Agendia, are done on the patient’s untreated specimen and gives you a result that is not dependent on any treatment regimen (i.e. Hormonal or chemotherapy). You know exactly what the likelihood of recurrence is to help decide your treatment plan. MammaPrint is the only FDA-cleared breast cancer test.

 

  • Definitive Results: Only MammaPrint provides an actionable High Risk or Low Risk result for every patient tested.